Leathanach 1 ó 44 torthaí
FIELD OF THE INVENTION
This invention relates to topical compositions containing phenolic anti-inflammatory agents partially encapsulated within multilamellar vesicles, and methods for making thereof. The invention also relates to the uses of such topical compositions to help prevent solar
BACKGROUND OF THE INVENTION
The present invention relates to substituted phenolic thioethers, sulfoxides, and disulfides and more particularly relates to the novel compounds of formula I which are specific 5-lipoxygenase inhibitors and are useful, for example, as anti-inflammatory and anti-allergy
This application is a 371 of PCT/JP00/00154 filed Jan. 14, 2000.
TECHNICAL FIELD
This invention relates to a pharmaceutical composition containing a compound having a phenolic hydroxyl group with coloring change being controlled, in detail a pharmaceutical composition comprising an anti-inflammatory
BACKGROUND OF THE INVENTION
The present invention relates to substituted phenolic thioalkylamides and more particularly relates to the novel compounds of Formula I which are specific 5-lipoxygenase inhibitors and are useful, for example, as anti-inflammatory and anti-allergy agents.
It is well
BACKGROUND OF THE INVENTION
The present invention relates to substituted phenolic thioalkylamides and more particularly relates to the novel compounds of Formula I which are specific 5-lipoxygenase inhibitors and are useful, for example, as anti-inflammatory and anti-allergy agents.
It is well
BACKGROUND OF THE INVENTION
The present invention relates to substituted phenolic thioether derivatives and more particularly relate to the novel compounds of Formula I which are specific 5-lipoxygenase inhibitors and are useful, for example, as anti-inflammatory and anti-allergy agents.
It is well
BACKGROUND OF THE INVENTION
The present invention relates to substituted phenolic thioether derivatives and more particularly relates to the novel compounds of Formula I which are specific 5-lipoxygenase inhibitors and are useful, for example, as anti-inflammatory and anti-allergy agents.
It is well
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to cyclic phenolic thioethers and more particularly relates to the novel compounds of Formula I which are 5-lipoxygenase inhibitors. The compounds of Formula I are useful, for example, as anti-inflammatory and
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to cyclic phenolic thioethers and more particularly relates to the novel compounds of Formula I which are 5-lipoxygenase inhibitors. The compounds of Formula I are useful, for example, as anti-inflammatory and
BACKGROUND OF THE INVENTION
The present invention relates to substituted phenolic thioethers and more particularly relates to the novel compounds of formula I which are specific 5-lipoxygenase inhibitors and are useful, for example, as anti-inflammatory and anti-allergy agents.
It is well recognized
BACKGROUND OF THE INVENTION
The present invention relates to substituted phenolic thioethers and more particularly relates to the novel compounds of formula I which are specific 5-lipoxygenase inhibitors and are useful, for example, as anti-inflammatory and anti-allergy agents.
It is well recognized
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to phenolic thioetheramides and more particularly relates to the novel compounds of formula I which are specific 5-lipoxygenase inhibitors and are useful, for example, as anti-inflammatory, and anti-allergy agents.
TECHNICAL FIELD
The disclosure relates to phenolic compositions derived from apple skin and uses thereof in the prevention and treatment diseases and conditions associated with oxidative stress and/or inflammation.
BACKGROUND
Natural plant-based phenolic compounds, such as flavonoids, have received
TECHNICAL FIELD
The disclosure relates to phenolic compositions derived from apple skin and uses thereof in the prevention and treatment diseases and conditions associated with oxidative stress and/or inflammation.
BACKGROUND
Natural plant-based phenolic compounds, such as flavonoids, have received
REFERENCE TO SEQUENCE LISTING SUBMITTED ELECTRONICALLY
The official copy of the sequence listing is submitted electronically via EFS-Web as an ASCII formatted sequence listing, created on Aug. 5, 2009, with a file named "604.sub.--29993 Sequence_Listing OSURF-08051.txt", and having a size of 3